Upregulation of GFAP is a common finding in diverse brain disorders, including Alzheimer’s disease, Parkinson’s disease, and many other disorders characterized by clinically significant tissue damage. Here, GFAP is linked to early-onset autosomal dominant Alzheimer disease.